Science / Alzheimer's disease FDA Approves Controversial New Alzheimer's Drug Biogen's aducanumab receives green light, despite questions about effectiveness By Newser Editors and Wire Services Posted Jun 7, 2021 8:30 AM CDT Updated Jun 7, 2021 10:30 AM CDT Copied Back